ResMed Inc. reported a strong third quarter in fiscal year 2023, marked by a 29% increase in revenue to $1,116.9 million and a 28% rise in operating profit. The company saw robust growth in device sales, driven by increased production and delivery of cloud-connected flow generator devices, as well as strong performance in mask and patient interfaces businesses. The Software-as-a-Service (SaaS) business also contributed significantly with a 35% revenue increase.